Hyaluronan degrading silica nanoparticles for skin cancer therapy

Nanoscale

Volumn 5, Issue 20, 2013, Pages 9690-9698

  Scodeller, P ^a   Catalano, P N ^a   Salguero, N ^a   Duran, H ^a   Wolosiuk, A ^a   Soler Illia, G J A A ^a  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DEGRADING ENZYMES; ENERGY DISPERSIVE X RAY SPECTROSCOPY; ENZYMATIC ACTIVITIES; EXTRACELLULAR MATRICES; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; LAYER-BY-LAYER SELF-ASSEMBLY TECHNIQUE; SILICA NANOPARTICLES; UV-VIS SPECTROSCOPY;

DERMATOLOGY; DYNAMIC LIGHT SCATTERING; ENZYME ACTIVITY; FIELD EMISSION MICROSCOPES; ONCOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS; ULTRAVIOLET VISIBLE SPECTROSCOPY; X RAY SPECTROSCOPY;

HYALURONIC ACID;

ANTINEOPLASTIC AGENT; CARBOPLATIN; DRUG CARRIER; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; IMMOBILIZED ENZYME; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL; CHEMISTRY; FEMALE; HUMAN; MELANOMA; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; POROSITY; SKIN NEOPLASMS; XENOGRAFT; ARTICLE; SKIN TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; DRUG CARRIERS; ENZYMES, IMMOBILIZED; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MELANOMA; MICE; MICE, NUDE; NANOPARTICLES; POROSITY; SILICON DIOXIDE; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84884874863     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c3nr02787b     Document Type: Article

References (43)

1. L. H. Bookbinder A. Hofer M. F. Haller et al. A recombinant human enzyme for enhanced interstitial transport of therapeutics J. Controlled Release 2006 114 230 241
2. L. Eikenes M. Tari I. Tufto O. S. Bruland C. de Lange Davies Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts Br. J. Cancer 2005 93 81 88
3. I. Muckenschnabel G. Bernhardt T. Spruss A. Buschauer Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice Cancer Chemother. Pharmacol. 1996 38 88 94
4. B. P. Toole Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities Clin. Cancer Res. 2009 15 7462 7468
5. M. A. Jacobetz D. S. Chan A. Neesse et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer Gut 2013 62 112 120
6. H. O. Fadnes R. K. Reed K. Aukland Interstitial fluid pressure in rats measured with a modified wick technique Microvasc. Res. 1977 14 27 36
7. C. H. Heldin K. Rubin K. Pietras A. Ostman High interstitial fluid pressure-an obstacle in cancer therapy Nat. Rev. Cancer 2004 4 806 813
8. P. P. Provenzano S. R. Hingorani Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer Br. J. Cancer 2013 108 1 8
9. E. J. Menzel C. Farr Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses Cancer Lett. 1998 131 3 11
10. S. Sakai K. Hirano H. Toyoda R. J. Linhardt T. Toida Matrix assisted laser desorption ionization-time of flight mass spectrometry analysis of hyaluronan oligosaccharides Anal. Chim. Acta 2007 593 207 213
11. L. Soltes G. Kogan M. Stankovska et al. Degradation of high-molar-mass hyaluronan and characterization of fragments Biomacromolecules 2007 8 2697 2705
12. K. Sugahara S. Yamada M. Sugiura et al. Identification of the reaction products of the purified hyaluronidase from stonefish (Synanceja horrida) venom Biochem. J. 1992 283 Pt 1 99 104
13. A. L. Dunn J. E. Heavner G. Racz M. Day Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management Expert Opin. Biol. Ther. 2010 10 127 131
14. Hyaluronidase Monograph (Amphadase, Hydase, Vitrase, Hylenex) Final, in: National PBM Drug Monograph, http://www.pbm.va.gov/Clinical%20Guidance/ Drug%20Monographs/Hyaluronidase%20Monograph%20(Amphadase,%20Hydase,%20Vitrase, %20Hylenex)%20Final.doc:, VHA Pharmacy Benefits Management Service and the Medical Advisory Panel, Washington, DC, 2008
15. C. J. Whatcott H. Han R. G. Posner G. Hostetter D. D. Von Hoff Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look Cancer Discovery 2011 1 291 296
16. ClinicalTrials.gov.in, http://www.clinicaltrials.gov/ct2/results?term= PEGPH20&Search=Search:, U.S. National Institutes of Health
17. C. Brekken C. de Lange Davies Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner Cancer Lett. 1998 131 65 70
18. P. P. Provenzano C. Cuevas A. E. Chang V. K. Goel D. D. Von Hoff S. R. Hingorani Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma Cancer cell 2012 21 418 429
19. K. Beckenlehner S. Bannke T. Spruss G. Bernhardt H. Schonenberg W. Schiess Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo J. Cancer Res. Clin. Oncol. 1992 118 591 596
20. S. Guedan J. J. Rojas A. Gros E. Mercade M. Cascallo R. Alemany Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth Mol. Ther. 2010 18 1275 1283
21. S. Ganesh M. Gonzalez-Edick D. Gibbons M. Van Roey K. Jooss Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models Clin. Cancer Res. 2008 14 3933 3941
22. S. Lavilla-Alonso M. M. Bauer U. Abo-Ramadan et al. Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development Cancer Gene Ther. 2012 19 126 134
23. C. Brekken M. H. Hjelstuen O. S. Bruland C. de Lange Davies Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts Anticancer Res. 2000 20 3513 3519
24. M. Gary-Bobo D. Brevet N. Benkirane-Jessel et al. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells Photodiagn. Photodyn. Ther. 2012 9 256 260
25. J. M. Rosenholm V. Mamaeva C. Sahlgren M. Linden Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage Nanomedicine 2012 7 111 120
26. G. I. Frost Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration Expert Opin. Drug Delivery 2007 4 427 440
27. W. Stöber A. Fink E. Bohn Controlled growth of monodisperse silica spheres in the micron size range J. Colloid Interface Sci. 1968 26 62 69
28. M. Benezra O. Penate-Medina P. B. Zanzonico et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma J. Clin. Invest. 2011 121 2768 2780
29. G. Durgun K. Ocakoglu S. Ozcelik Systematic Tuning the Hydrodynamic Diameter of Uniformed Fluorescent Silica Nanoparticles J. Phys. Chem. C 2011 115 16322 16332
30. G. Decher Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites Science 1997 277 1232 1237
31. F. Caruso H. Lichtenfeld E. Donath H. Möhwald Investigation of Electrostatic Interactions in Polyelectrolyte Multilayer Films: Binding of Anionic Fluorescent Probes to Layers Assembled onto Colloids Macromolecules 1999 32 2317 2328
32. P. Scodeller R. Carballo R. Szamocki L. Levin F. Forchiassin E. J. Calvo Layer-by-layer self-assembled osmium polymer-mediated laccase oxygen cathodes for biofuel cells: the role of hydrogen peroxide J. Am. Chem. Soc. 2010 132 11132 11140
33. P. Scodeller V. Flexer R. Szamocki et al. Wired-enzyme core-shell Au nanoparticle biosensor J. Am. Chem. Soc. 2008 130 12690 12697
34. V. Flexer E. S. Forzani E. J. Calvo S. J. Luduena L. I. Pietrasanta Structure and thickness dependence of "molecular wiring" in nanostructured enzyme multilayers Anal. Chem. 2006 78 399 407
35. M. W. Li A. I. Yudin K. R. Robertson G. N. Cherr J. W. Overstreet Importance of glycosylation and disulfide bonds in hyaluronidase activity of macaque sperm surface PH-20 J. Androl. 2002 23 211 219
36. F. Caruso C. Schüler Enzyme Multilayers on Colloid Particles: Assembly, Stability, and Enzymatic Activity Langmuir 2000 16 9595 9603
37. W. Schärtl, Light Scattering from Polymer Solutions and Nanoparticle Dispersions, Springer, New York, 2007
38. D. S. Monteiro T. M. Nobre M. E. Zaniquelli Hyaluronidase behavior at the air/liquid and air/lipid interfaces and improved enzymatic activity by its immobilization in a biomembrane model J. Phys. Chem. B 2011 115 4801 4809
39. E. A. Turley M. Tretiak Glycosaminoglycan production by murine melanoma variants in vivo and in vitro Cancer Res. 1985 45 5098 5105
40. H. Meng M. Liong T. Xia et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line ACS Nano 2010 4 4539 4550
41. A. Baeza E. Guisasola E. Ruiz-Hernández M. Vallet-Regí Magnetically Triggered Multidrug Release by Hybrid Mesoporous Silica Nanoparticles Chem. Mater. 2012 24 517 524
42. S. R. Hingorani W. P. Harris J. T. Beck et al. A phase Ib study of gemcitabine plus PEGPH20 (pegylated recombinant human hyaluronidase) in patients with stage IV previously untreated pancreatic cancer. In: 2013 American Society of Clinical Oncology Annual Meeting, Chicago, IL J. Clin. Oncol. 2013 31 suppl. 4010
43. Sigma-Aldrich. Enzymatic Assay of Hyaluronidase, http://www.sigmaaldrich. com/technical-documents/protocols/biology/enzymatic-assay-of-hyaluronidase.html